Lessee, Operating Lease, Liability, to be Paid, Year Three of Propanc Biopharma, Inc. from 30 Jun 2022 to 30 Jun 2025
Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Propanc Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 30 Jun 2022 to 30 Jun 2025.
Propanc Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Jun 2025 was $21,734.
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.